N
NewLeaf Symbiotics
Science-based company doing cutting-edge research and product development, using a naturally occurring family of beneficial plant bacteria
About NewLeaf Symbiotics
NewLeaf Symbiotics is an agricultural biotechnology company that develops and commercializes products based on a family of beneficial bacteria known as Pink Pigmented Facultative Methylotrophs (PPFMs). The company's core business revolves around harnessing these naturally occurring microbes to create sustainable agricultural solutions that can enhance crop health and yield.
NewLeaf Symbiotics serves the agricultural market, with its products being applied to a variety of crops. The company's business model is centered on the research, development, and subsequent sale of these proprietary microbial products. It generates revenue through the commercialization of its PPFM-based technologies, which are offered as seed treatments or in-furrow applications to improve plant performance.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- Creve Coeur, United States
- Employees
- 49
- Open positions
- None listed
- Dealroom signal
- 74.6/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Crop Protection, Precision Agriculture, Synthetic Biology, Sustainable Development Goals, Climate Tech, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 1 company, latest Dec 2013
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Dec 2023 | $45M | $180M | Otter Capital · S2G Investments · Leaps by Bayer · Gullspång Re:food | ↗ |
| CONVERTIBLEOther financing | Dec 2021 | $10M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for NewLeaf Symbiotics is 2.2K monthly website visits, up 4.8% over the last three months. NewLeaf Symbiotics's team declined 5.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Open Prairie
Pangaea Ventures
RockPort Capital- PIPalo Alto Investors
Series B and later12 investors entered at this stage
- OCOtter Capital
Monsanto
The Yard Ventures
Lewis & Clark Ventures
Alumni Ventures
S2G Investments
Koch Agronomic Services
Koch Industries
SABIC
Bayer
Leaps by Bayer
Gullspång Re:food
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NewLeaf Symbiotics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NewLeaf Symbiotics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.